These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12735318)

  • 1. Genetics of cell-mediated lympholysis (CML) in man.
    Singal DP; Wadia YJ
    Tissue Antigens; 1980 Feb; 15(2):177-88. PubMed ID: 12735318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of cytotoxic T lymphocytes in HLA-A, -B and -C-identical responder-stimulator pairs. I. Variations in generation of anti-class-II CTL in primary mixed lymphocyte cultures.
    Breuning MH; Breur BS; Engelsma MY; Iványi P
    Tissue Antigens; 1984 Aug; 24(2):81-9. PubMed ID: 6238446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cloned cytotoxic T-lymphocyte (CTL) line recognizing a subtype of HLA B27.
    Breuning MH; Spits H; de Vries JE; Iványi P
    Hum Immunol; 1984 Apr; 9(4):231-42. PubMed ID: 6201469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-expression of HLA-B7 and HLA-B27 alleles is associated with B7-restricted immunodominant responses following influenza infection.
    Akram A; Inman RD
    Eur J Immunol; 2013 Dec; 43(12):3254-67. PubMed ID: 24113999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of human CML target. HLA-B locus (B12) antigen variants defined by CTL generated between B locus-identical (B12) responder-stimulator pairs.
    Kato S; Iványi P; Lacko E; Breur B; Du Bois R; Eijsvoogel VP
    J Immunol; 1982 Feb; 128(2):949-55. PubMed ID: 6976390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of cytotoxic T lymphocytes in HLA-A, -B and -C-identical responder-stimulator pairs. II. New subtypes of HLA-Bw35.
    Breuning MH; Breur BS; Engelsma MY; Goulmy E; Iványi P
    Tissue Antigens; 1984 Aug; 24(2):90-7. PubMed ID: 6208634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual differences in the cytotoxic T-lymphocyte response in man to public HLA determinants.
    Breur-Vriesendorp BS; Ivanyi P
    Cell Immunol; 1986 Dec; 103(2):252-71. PubMed ID: 3492287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation on immunogenicity by HLA-B27 subtype polymorphism.
    Jaraquemada D; Galocha B; Aparicio P; Rojo S; Calvo V; López de Castro JA
    Eur J Immunol; 1988 Dec; 18(12):1945-50. PubMed ID: 2464494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of anti-HLA-B27 cytotoxic T lymphocytes.
    Breuning MH; Breur BS; Engelsma MY; Huis B; Iványi P
    Tissue Antigens; 1983 Oct; 22(4):267-82. PubMed ID: 6606238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two subgroups of HLA Bw44 defined by cell-mediated lympholysis that differ in Bw44 expression on platelets and in patterns of genetic linkage disequilibrium.
    Tekolf WA; Biddison WE; Aster RD; Shaw S
    J Immunol; 1982 Oct; 129(4):1474-8. PubMed ID: 6180011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delineation of determinants on HLA-B7 and HLA-B27 that are necessary for cytolytic T cell recognition by using inter- and intra-domain recombinants.
    Healy F; Toubert A; Gomard E; Jordan BR; Levy JP
    J Immunol; 1989 Oct; 143(7):2357-63. PubMed ID: 2476507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HLA-B7/HLA-B44 strong cross immunoreactivity observed in flow cytometry HLA-B27 immunotyping.
    Francois F; Waeckel L; Berger AE; Lambert C
    Cytometry A; 2024 May; 105(5):376-381. PubMed ID: 38379087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakdown of CTL tolerance to self HLA-B*2705 induced by exposure to Chlamydia trachomatis.
    Popov I; Dela Cruz CS; Barber BH; Chiu B; Inman RD
    J Immunol; 2002 Oct; 169(7):4033-8. PubMed ID: 12244206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
    Yannelli JR; Moore LC; Engelhard VH
    J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HC restricted dual specific inhibition of mixed leukocyte culture reactions by human HLA antibody molecules.
    de Rooij-Doyer E; Jonker M; Bruning JW; van Rood JJ
    Tissue Antigens; 1980 Jan; 15(1):47-59. PubMed ID: 12735332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the functional epitopes on different HLA-A2 molecules.
    Goulmy E; van der Poel J; Giphart M; van Rood JJ
    Immunogenetics; 1984; 20(1):13-21. PubMed ID: 6204938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.
    Burrows SR; Khanna R; Burrows JM; Moss DJ
    J Exp Med; 1994 Apr; 179(4):1155-61. PubMed ID: 7511682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of responder cell activity in mixed leukocyte culture reactions. I. Evidence of cross-reactivity of B7-antibody with HLA-B8.
    de Rooij-Doyer E; Bruning JW; van Rood JJ
    Tissue Antigens; 1981 Sep; 18(3):154-65. PubMed ID: 7336421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential recognition of the serologically defined HLA-A2 antigen by allogeneic cytotoxic T cells. II. Definition of three HLA-A2 subtypes by CTLs.
    van der Poel JJ; Pool J; Goulmy E; van Rood JJ
    Immunogenetics; 1983; 17(6):599-608. PubMed ID: 6190741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimates of cytotoxic T-lymphocyte precursor frequencies against HLA class I antigens in responder-stimulator pairs with a negative mixed lymphocyte culture reaction.
    Slavcev AS; Breur-Vriesendorp BS; Ivanyi P
    Hum Immunol; 1995 Oct; 44(2):97-102. PubMed ID: 8847234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.